Jamieson Wellness (TSE:JWEL) Insider Paul Michael Galbraith Sells 7,905 Shares

Key Points

• Jamieson Wellness insider Paul Michael Galbraith sold 7,905 shares of the company, reducing his ownership by 59.57%, with a total sale value of C$288,510.37.
• The stock price of Jamieson Wellness rose by 0.2% to reach C$37.01, while trading volume was lower than average.
• Several analysts have increased their price targets for Jamieson Wellness, with TD Securities raising its target to C$45.00 and maintaining a "buy" rating.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) insider Paul Michael Galbraith sold 7,905 shares of the company's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of C$36.50, for a total transaction of C$288,510.37. Following the completion of the sale, the insider directly owned 5,366 shares in the company, valued at approximately C$195,843.98. The trade was a 59.57% decrease in their position.

Jamieson Wellness Price Performance

Jamieson Wellness stock traded up C$0.25 during trading hours on Friday, hitting C$37.22. 63,365 shares of the stock were exchanged, compared to its average volume of 69,856. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76. The stock has a market capitalization of C$1.55 billion, a P/E ratio of 27.98 and a beta of 1.29. Jamieson Wellness Inc. has a 12 month low of C$27.90 and a 12 month high of C$38.20. The business's 50-day moving average is C$35.74 and its two-hundred day moving average is C$33.63.

Wall Street Analyst Weigh In

Several brokerages have weighed in on JWEL. TD Securities upped their price objective on shares of Jamieson Wellness from C$42.00 to C$45.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. BMO Capital Markets increased their price target on shares of Jamieson Wellness from C$41.00 to C$42.00 and gave the company an "outperform" rating in a research note on Friday, August 8th. Finally, National Bankshares increased their price target on shares of Jamieson Wellness from C$40.00 to C$40.60 and gave the company an "outperform" rating in a research note on Friday, August 8th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Jamieson Wellness currently has a consensus rating of "Buy" and an average target price of C$42.40.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.